Bridgene Biosciences Inc.

San Jose, CA

UEI
ECKNZL5KZVK7
CAGE
87KA9
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
75 Nicholson Ln, San Jose, CA 95134, USA
Website
bridgenebio.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid… R41CA250761 National Cancer Institute (NIH) $298,928
A novel chemical proteomics platform to expand druggable space R43GM130180 National Institute of General Medical Sciences (NIH) $223,000

Quick answers

Is Bridgene Biosciences Inc. registered in SAM.gov?

Yes. Bridgene Biosciences Inc.'s SAM.gov registration is active through March 18, 2027.

What is Bridgene Biosciences Inc.'s most recent federal award?

Bridgene Biosciences Inc.'s most recent federal grant award is Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid… (R41CA250761), from National Cancer Institute (NIH), on September 18, 2020.

On GovTribe

See Bridgene Biosciences Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login